Newton Samuel S, Duman Ronald S
Laboratory of Molecular Psychiatry, Departments of Psychiatry and Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06508, USA.
Mol Pharmacol. 2006 Aug;70(2):440-3. doi: 10.1124/mol.106.027078. Epub 2006 May 25.
Regulation of gene expression is known to contribute to the long-term adaptations underlying the effects of psychotropic drugs, including the actions of antidepressants and drugs of abuse in behavioral models. However, the precise molecular events that are required for modification of chromatin and that underlie gene repression or activation have not been elucidated. Recent reports, including the article by Cassel et al. in this issue of Molecular Pharmacology, address this question and demonstrate that psychotropic drugs modify specific methyl-CpG-binding proteins that control histone acetylation and gene expression.
已知基因表达调控有助于精神药物作用背后的长期适应性变化,包括抗抑郁药和成瘾药物在行为模型中的作用。然而,染色质修饰所需的精确分子事件以及基因抑制或激活的基础尚未阐明。最近的报道,包括本期《分子药理学》中卡塞尔等人的文章,探讨了这个问题,并证明精神药物会修饰特定的甲基CpG结合蛋白,这些蛋白控制组蛋白乙酰化和基因表达。